Oxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma(MZL)
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The investigators are willing to investigate the efficacy and safety of oxaliplatin and
prednisolone (Ox-P) combination in patients with previously treated MZL who have a few
clinical trial data.
Phase:
Phase 2
Details
Lead Sponsor:
Dong-A University Hospital
Collaborators:
Asan Medical Center Chonnam National University Hospital Chung-Ang University Korea Cancer Center Hospital Korea University Kyungpook National University Kyungpook National University Hospital Samsung Medical Center